pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
roxadustat
Myelodysplastic Syndrome (Preleukemia)
Hypoxia-inducible factor prolyl hydroxylase
$KYNBKYNTRA BIO, INC.
0 catalysts
Marketed
rufinamide
Banzel (rufinamide)
Lennox-Gastaut Syndrome
Eisai Co Ltd
0 catalysts
pre_registration
rusfertide acetate
Polycythemia Vera
$PTGXProtagonist Therapeutics, Inc
0 catalysts
← prev
page 215 of 231
next →
131
Pain89
Neurology1
Phase 2
ruxoprubart
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
0 catalysts
Phase 2
ruxotemitide
Oncopore (ruxotemitide [INN])
Metastatic Melanoma
Lytix Biopharma ASA
0 catalysts
Phase 2
sabirnetug
Alzheimer's Disease
$ABOSAcumen Pharmaceuticals, Inc.
0 catalysts
Preclinical
sabizabulin hydrochloride
Ebolavirus Infections (Ebola Hemorrhagic Fever)
$VERUVERU INC.
0 catalysts
Phase 2
sacituzumab drozuntecan
sacituzumab drozuntecan [INN]
Epithelial Ovarian Cancer
$BNTXBioNTech SE
0 catalysts
Phase 3
sacituzumab tirumotecan
Adenocarcinoma Of The Gastroesophageal Junction
$MRKMerck & Co., Inc.
0 catalysts
Marketed
sacrosidase
Sucraid (sacrosidase)
Congenital Sucrase-Isomaltase Deficiency (CSID)
QOL Medical LLC
0 catalysts
Marketed
safinamide mesylate
Safinamide Mesylate (safinamide mesylate)
Parkinson's Disease
Zenara Pharma Pvt Ltd
0 catalysts
Phase 3
safusidenib
safusidenib [INN]
Malignant Glioma
$NUVBNuvation Bio Inc.
0 catalysts
Phase 3
salanersen
Spinal Muscular Atrophy (SMA)
$BIIBBIOGEN INC.
0 catalysts
Marketed
salmeterol xinafoate
Serevent Diskus (salmeterol xinafoate)
Asthma
GlaxoSmithKline LLC
0 catalysts
Preclinical
salsalate
Polycystic Kidney Disease
J and D Pharmaceuticals LLC
0 catalysts
Phase 2
samelisant
samelisant [INN]
Narcolepsy
Suven Life Sciences Ltd
0 catalysts
Phase 2
sapablursen sodium
Polycythemia Vera
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 2
saracatinib difumarate
Idiopathic Pulmonary Fibrosis
$AZNASTRAZENECA PLC
0 catalysts
Marketed
sarecycline hydrochloride
Seysara (sarecycline hydrochloride)
Acne Vulgaris
Almirall SA
0 catalysts
Phase 3
sargramostim
Leukine (sargramostim)
Metastatic Melanoma
Granulocyte-macrophage colony-stimulating factor receptor
Partner Therapeutics Inc
0 catalysts
Phase 2
sarilumab
Kevzara (sarilumab)
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Interleukin-6 receptor subunit alpha
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
saroglitazar magnesium
Lipaglyn (saroglitazar magnesium)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Zydus Therapeutics Inc
0 catalysts
Phase 3
satralizumab
Enspryng (satralizumab-mwge)
Demyelinating Diseases
IL6Ralpha/GP130
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
satricabtagene autoleucel
Adenocarcinoma Of The Gastroesophageal Junction
CARsgen Therapeutics Holdings Ltd
0 catalysts
Phase 2
savolitinib
Non-Small Cell Lung Cancer
Hepatocyte growth factor receptor
$AZNASTRAZENECA PLC
0 catalysts
Marketed
saxagliptin
Saxagliptin (saxagliptin)
Type 2 Diabetes
Glenmark Pharmaceuticals Ltd
0 catalysts
Marketed
scorpion [centruroides] (polyvalent) immunoglobulin F(ab’) 2 antivenom [equine]
Anascorp
Poisoning
Rare Disease Therapeutics Inc
0 catalysts
Marketed
sebelipase alfa
Kanuma (sebelipase alfa)
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals Inc
0 catalysts
Marketed
sebetralstat
Ekterly (sebetralstat [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$KALVKalVista Pharmaceuticals, Inc.
0 catalysts
Marketed
secnidazole
Solosec (secnidazole)
Bacterial Vaginosis
$EVFMEvofem Biosciences, Inc.
0 catalysts